Mesenchymal Stem Cells: An Overview of Their Potential in Cell-Based Therapy for Diabetic Nephropathy

Table 2

Ongoing or completed clinical trials with MSC-based therapy in DN.

ClinicalTrials.gov identifier	Cell type	Subject number	Cell dosage	Route	Trial status
NCT01843387	BM-MPC	30	1 dose: 150, cells	IV	Completed
NCT02585622	BM-MSCs	48	1 dose: 80, 160, cells	IV
NCT04216849	UC-MSCs	54	5 doses: cells/kg	IV	Phase 2
NCT03288571	UC-MSCs	20	3 doses: 1 ml cell suspension	Renal parenchyma	Phase 2
NCT03840343	AD-MSCs	30	2 doses: 2.5, cells/kg	Intra-arterial delivery	Phase 1
NCT04125329	UC-MSCs	15	3 doses: cells/kg	IV	Early phase 1